CRIS Current Research Information System

CAMPADELLI, MARIA GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.657
AS - Asia 4.967
EU - Europa 4.071
AF - Africa 307
SA - Sud America 298
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.589
SG - Singapore 1.418
VN - Vietnam 1.294
CN - Cina 1.289
IT - Italia 999
GB - Regno Unito 783
DE - Germania 498
SE - Svezia 425
HK - Hong Kong 301
FR - Francia 242
BR - Brasile 222
IN - India 202
CH - Svizzera 189
UA - Ucraina 185
IE - Irlanda 177
RU - Federazione Russa 166
JP - Giappone 101
NL - Olanda 99
TG - Togo 96
KR - Corea 78
ZA - Sudafrica 72
FI - Finlandia 71
SC - Seychelles 59
BG - Bulgaria 55
AR - Argentina 46
CI - Costa d'Avorio 45
EE - Estonia 40
CA - Canada 36
JO - Giordania 32
PH - Filippine 32
TH - Thailandia 32
ID - Indonesia 31
TR - Turchia 31
BE - Belgio 28
MX - Messico 23
PL - Polonia 23
BD - Bangladesh 22
AT - Austria 20
IQ - Iraq 18
ES - Italia 12
GR - Grecia 11
PK - Pakistan 10
SA - Arabia Saudita 10
AU - Australia 9
KE - Kenya 9
LT - Lituania 9
TW - Taiwan 9
EC - Ecuador 8
MY - Malesia 8
DK - Danimarca 7
CO - Colombia 6
EU - Europa 6
RO - Romania 6
UZ - Uzbekistan 6
EG - Egitto 5
HR - Croazia 5
RS - Serbia 5
CL - Cile 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
IR - Iran 4
KZ - Kazakistan 4
LK - Sri Lanka 4
MA - Marocco 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
IL - Israele 3
LB - Libano 3
PE - Perù 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CM - Camerun 2
CZ - Repubblica Ceca 2
LA - Repubblica Popolare Democratica del Laos 2
MZ - Mozambico 2
NO - Norvegia 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
Totale 15.308
Salva come PNG Salva come JPEG
Città #
Singapore 949
Southend 654
Ashburn 544
Fairfield 501
Chandler 476
Ho Chi Minh City 340
Santa Clara 330
Bologna 315
San Jose 305
Hong Kong 284
Hanoi 279
Woodbridge 226
Seattle 212
Princeton 200
Ann Arbor 197
Houston 192
Wilmington 185
Hefei 178
Dublin 176
Beijing 170
Bern 156
Dallas 153
Cambridge 151
Boardman 148
Jacksonville 129
New York 105
Los Angeles 99
Lomé 96
Dong Ket 94
Lauterbourg 94
Tokyo 92
Berlin 76
Turin 67
Seoul 62
Helsinki 61
Westminster 57
Bremen 55
Milan 55
Sofia 55
Nanjing 54
Padova 51
Da Nang 50
Abidjan 45
Buffalo 43
Jinan 41
Guangzhou 40
Haiphong 38
Redmond 38
Shanghai 35
Council Bluffs 33
São Paulo 33
San Diego 32
Changsha 31
Frankfurt am Main 31
Bulle 29
Amman 28
Genoa 28
Redondo Beach 28
Brussels 27
Johannesburg 25
Jakarta 24
Shenyang 24
Hải Dương 23
Nanchang 23
Mülheim 22
Saint Petersburg 22
Hebei 21
Tianjin 21
Bengaluru 19
Nuremberg 18
Phoenix 18
Brooklyn 17
Olalla 17
Des Moines 16
London 16
Munich 16
Redwood City 16
Rome 16
Shijiazhuang 16
Falkenstein 15
Medford 15
Quận Bình Thạnh 15
Chicago 14
Ravenna 14
Biên Hòa 13
Istanbul 13
Rimini 13
Stockholm 13
Warsaw 13
Pune 12
Taizhou 12
Zhengzhou 12
Baghdad 11
Can Tho 11
Jiaxing 11
Mahé 11
Thái Nguyên 11
Toronto 11
Amsterdam 10
Atlanta 10
Totale 9.903
Salva come PNG Salva come JPEG
Nome #
Type I Interferon and NF- B Activation Elicited by Herpes Simplex Virus gH/gL via  v 3 Integrin in Epithelial and Neuronal Cell Lines 416
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model 335
Rescue, Purification, and Characterization of a Recombinant HSV Expressing a Transgenic Protein 276
oHSV Genome Editing by Means of galK Recombineering 269
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 245
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors 240
Retargeting strategies for oncolytic herpes simplex viruses 234
A heptad repeat in herpes simplex virus-1 gH, located downstream of the α-helix with attributes of a fusion peptide, is critical for virus entry and fusion. 232
Rethinking herpes simplex virus: the way to oncolytic agents. 232
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 232
HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses 228
Viral and cellular contributions to herpes simplex virus entry into the cell 225
Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD. 220
The simultaneous insertion of two ligands in gD for the cultivation of oncolytic HSVs in non-cancer cells and the retargeting to cancer receptors 217
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy 216
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 216
The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2. 213
The ectodomain of herpes simplex virus glycoprotein H contains a membrane alpha-helix with attributes of an internal fusion peptide, positionally conserved in the herpesviridae family. 212
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice 207
Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins 205
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion 204
A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors. 203
MODIFICAZIONE DEL TROPISMO DEL VIRUS HERPES SIMPLEX VERSO RECETTORI SELEZIONATI 201
Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells 198
A strategy for cultivation of retargeted oncolytic herpes simplex viruses in non-cancer cells 197
Coexpression of UL20p and gK inhibits cell-cell fusion mediated by herpes simplex virus glycoproteins gD, gH-gL, and wild-type gB or an endocytosis-defective gB mutant and downmodulates their cell surface expression. 194
alphav-beta3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1. 192
Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL in part through the C-terminal profusion domain. 188
Integrins as Herpesvirus Receptors and Mediators of the Host Signalosome 187
Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2 186
Herpes Simplex Virus Glycoproteins gH/gL and gB Bind Toll-Like Receptor 2, and Soluble gH/gL Is Sufficient To Activate NF-kB. 184
The multipartite system that mediates entry of herpes simplex virus into the cell 183
Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv 183
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers 181
Herpesviruses as oncolytic agents 179
The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. 176
The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors 176
Oncolytic herpes virus retargeted to HER-2. 173
Dissociation of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH activation and virus entry 168
Immunocompetent C57BL/6 mouse, engineered to be tolerant to the human HER2 receptor, as a model for the study of retargeted fully-virulent oncolytic Herpes Virus (HSV) 167
Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes. 166
αvβ3 Integrin boosts the innate immune response elicited in epithelial cells through plasma membrane and endosomal Toll-like receptors 166
Herpes simplex virus glycoproteins H/L bind to cells independently of alpha V- beta 3 integrin and inhibit virus entry, and their constitutive expression restricts infection. 165
The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors. 165
alphaV-beta3-Integrin Relocalizes nectin1 and Routes Herpes Simplex Virus to Lipid Rafts 164
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV 162
Alphaherpes viral genes and their functions 159
The egress of herpesviruses from cells: the unanswered questions. 158
Herpes simplex virus (HSV) with modified tropism, uses and process of preparation thereof. 157
Entry of alphaherpesviruses into the cell 156
The molecular basis of herpesviruses as oncolytic agents. 155
Specificity, safety, efficacy of egfrviii-retargeted oncolytic hsv for xenotransplanted human glioblastoma 155
Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion. 154
Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain. 154
Immunotherapeutic efficacy of retargeted ohsvs designed for propagation in an ad hoc cell line 154
U(L)27.5 Is a novel γ2 gene antisense to the herpes simplex virus 1 gene encoding glycoprotein B 151
αvβ6- and αvβ8-Integrins Serve As Interchangeable Receptors for HSV gH/gL to Promote Endocytosis and Activation of Membrane Fusion 150
The Epithelial αvβ3-Integrin Boosts the MYD88-Dependent TLR2 Signaling in Response to Viral and Bacterial Components 150
HSV glycoproteins and their roles in virus entry and egress 146
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D 146
{alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. 144
Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion. 142
Intracellular Trafficking and Maturation of Herpes Simplex Virus Type 1 gB and Virus Egress Require Functional Biogenesis of Multivesicular Bodies. 136
The egress of alphaherpesviruses from the cell 131
Fundamentals of Molecular Virology 124
Complexes between Herpes Simplex Virus Glycoproteins gD, gB, and gH Detected in Cells by Complementation of Split Enhanced Green Fluorescent Protein. 113
Comparison of murine and human nectin1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin1 to gD and a gD-dependent pathway of entry 103
Critical residues in the CC′ ridge of the human nectin1 receptor V domain enable herpes simplex virus entry into the cell and act synergistically with the downstream region 100
null 98
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells 96
null 95
Herpes simplex virus (HSV) glycoprotein h is partially processed in a cell line that expresses the glycoprotein and fully processed in cells infected with deletion or is mutants in the known hsv glycoproteins 91
Nectin2α (PRR2α or HveB) and nectin2δ are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D 87
Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection 85
Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL 84
Localization and putative function of the U(L)20 membrane protein in cells infected with herpes simplex virus 1 81
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry 79
Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, Nectin1 (PRR1/HveC/HIgR) and Nectin2 (PRR2/HveB) 79
Herpes simplex virus glycoprotein D is sufficient to induce spontaneous pH-independent fusion in a cell line that constitutively expresses the glycoprotein 79
The murine homolog of human Nectin1δ serves as a species nonspecific mediator for entry of human and animal αherpesviruses in a pathway independent of a detectable binding to gD 79
Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection 77
Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin4 bind to the predicted C-C′-C″-D β-strands of the nectin1 V domain 76
Conservation of the architecture of the Golgi apparatus related to a differential organization of microtubules in polykaryocytes induced by syn- mutants of herpes simplex virus 1 76
Targeted Delivery of IL-12 Adjuvants Immunotherapy by Oncolytic Viruses 75
The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells 73
Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus 73
The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1 72
CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B 72
The herpes simplex virus U(L)20 protein compensates for the differential disruption of exocytosis of virions and viral membrane glycoproteins associated with fragmentation of the Golgi apparatus 71
Human herpesvirus 6: An emerging pathogen 68
Identification of an 85 kDa phosphoprotein as an immunodominant protein specific for human herpesvirus 7-infected cells 67
Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6 66
Individual herpes simplex virus 1 glycoproteins display characteristic rates of maturation from precursor to mature form both in infected cells and in cells that constitutively express the glycoproteins 62
Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosis 61
Selection of a monoclonal antibody specific for variant B human herpesvirus 6-infected mononuclear cells 61
Substitution in the murine nectin1 receptor of a single conserved amino acid at a position distal from the herpes simplex virus gD binding site confers high-affinity binding to gD 60
N-acetylgalactosaminyltransferase activity involved in O-glycosylation of herpes simplex virus type 1 glycoproteins 58
The biology and natural history of two emerging pathogens: Human herpesviruses 6 and 7 57
Comparative study on O-linked oligosaccharides of glycoprotein D of herpes simplex virus types 1 and 2 54
Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes 52
Totale 15.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 0 0 0 0 0 0 0 68 64 191
2021/20221.496 103 40 122 88 108 78 65 137 93 92 315 255
2022/20232.120 225 280 96 229 158 154 59 135 347 67 177 193
2023/2024805 51 128 59 94 81 171 30 47 20 47 35 42
2024/20252.341 115 301 186 200 462 147 177 84 43 135 146 345
2025/20265.224 614 570 590 455 587 303 471 174 1.108 352 0 0
Totale 15.620